Mitsubishi UFJ Trust & Banking Corp Sells 124,583 Shares of Masimo Co. (NASDAQ:MASI)

Mitsubishi UFJ Trust & Banking Corp cut its holdings in shares of Masimo Co. (NASDAQ:MASIGet Rating) by 80.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 30,723 shares of the medical equipment provider’s stock after selling 124,583 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp owned 0.06% of Masimo worth $4,015,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in MASI. Vanguard Group Inc. increased its stake in Masimo by 1.5% in the first quarter. Vanguard Group Inc. now owns 4,775,660 shares of the medical equipment provider’s stock valued at $695,050,000 after acquiring an additional 71,918 shares during the last quarter. State Street Corp increased its stake in Masimo by 1.6% in the first quarter. State Street Corp now owns 1,730,991 shares of the medical equipment provider’s stock valued at $251,928,000 after acquiring an additional 27,261 shares during the last quarter. Liontrust Investment Partners LLP increased its stake in Masimo by 19.0% in the second quarter. Liontrust Investment Partners LLP now owns 1,199,300 shares of the medical equipment provider’s stock valued at $156,713,000 after acquiring an additional 191,700 shares during the last quarter. RTW Investments LP increased its stake in Masimo by 32.7% in the first quarter. RTW Investments LP now owns 1,127,593 shares of the medical equipment provider’s stock valued at $164,110,000 after acquiring an additional 277,622 shares during the last quarter. Finally, Champlain Investment Partners LLC boosted its position in Masimo by 0.6% in the first quarter. Champlain Investment Partners LLC now owns 975,547 shares of the medical equipment provider’s stock valued at $141,981,000 after buying an additional 5,860 shares in the last quarter. 93.31% of the stock is owned by institutional investors.

Insider Activity at Masimo

In related news, CEO Joe E. Kiani purchased 7,784 shares of the firm’s stock in a transaction on Friday, November 11th. The stock was purchased at an average cost of $129.27 per share, with a total value of $1,006,237.68. Following the completion of the purchase, the chief executive officer now owns 7,784 shares in the company, valued at approximately $1,006,237.68. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, CEO Joe E. Kiani purchased 7,784 shares of the firm’s stock in a transaction on Friday, November 11th. The stock was purchased at an average cost of $129.27 per share, with a total value of $1,006,237.68. Following the completion of the purchase, the chief executive officer now owns 7,784 shares in the company, valued at approximately $1,006,237.68. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Joe E. Kiani purchased 31,994 shares of the firm’s stock in a transaction on Monday, November 14th. The stock was bought at an average cost of $123.99 per share, with a total value of $3,966,936.06. Following the completion of the purchase, the chief executive officer now owns 39,778 shares of the company’s stock, valued at approximately $4,932,074.22. The disclosure for this purchase can be found here. 9.70% of the stock is owned by company insiders.

Masimo Price Performance

MASI stock opened at $141.46 on Friday. The firm has a market cap of $7.44 billion, a price-to-earnings ratio of 46.84 and a beta of 0.87. The company has a quick ratio of 1.28, a current ratio of 2.12 and a debt-to-equity ratio of 0.76. Masimo Co. has a 12-month low of $108.89 and a 12-month high of $305.21. The company’s fifty day simple moving average is $137.02 and its 200 day simple moving average is $139.27.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. Jefferies Financial Group assumed coverage on shares of Masimo in a research report on Wednesday, October 12th. They issued a “buy” rating and a $180.00 target price on the stock. Stifel Nicolaus raised their target price on shares of Masimo from $162.00 to $172.00 and gave the company a “buy” rating in a research report on Monday, September 12th. Needham & Company LLC raised their target price on shares of Masimo from $163.00 to $179.00 and gave the company a “buy” rating in a research report on Wednesday, August 10th. Loop Capital assumed coverage on shares of Masimo in a research report on Tuesday, September 13th. They issued a “buy” rating and a $206.00 target price on the stock. Finally, StockNews.com began coverage on shares of Masimo in a research report on Wednesday, October 12th. They issued a “hold” rating on the stock. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $190.29.

Masimo Profile

(Get Rating)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

See Also

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASIGet Rating).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.